Category: ameri-can
IP.TMK.NRCT
IP.TMK.NRCT Nombre de demandes de dépôt de marques, non-résidents Trademark applications filed are
View DetailsIT.NET.USER.ZS
IT.NET.USER.ZS Utilisateurs d Internet (% de la population) Internet users are individuals who hav
View DetailsSE.SEC.PROG.ZS
SE.SEC.PROG.ZS Accession à l’enseignement secondaire (%) Number of students admitted to the first
View DetailsSG.JOB.NOPN.EQ
SG.JOB.NOPN.EQ Les femmes peuvent occuper les mêmes emplois que les hommes (1=oui ; 0=non) Nonpreg
View DetailsROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)
ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment
View DetailsNOVOEIGHT 1 000 UI INJ FL + SRG (Turoctocog alfa)
NOVOEIGHT 1 000 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat
View DetailsNOVOEIGHT 1 500 UI INJ FL + SRG (Turoctocog alfa)
NOVOEIGHT 1 500 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat
View DetailsNOVOEIGHT 2 000 UI INJ FL + SRG (Turoctocog alfa)
NOVOEIGHT 2 000 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat
View DetailsNOVOEIGHT 250 UI INJ FL + SRG (Turoctocog alfa)
NOVOEIGHT 250 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treatme
View Details